Financial Daily from THE HINDU group of publications
Thursday, Oct 21, 2004
Financial Daily from THE HINDU group of publications Thursday, Oct 21, 2004 |
||
|
|
||
|
Corporate
-
Announcements Marketing - New Products & Services Industry & Economy - Health Natco Pharma launches cancer drug Our Bureau
Hyderabad , Oct. 20 NATCO Pharma Ltd (NPL) has announced the launch of anti-cancer drug Curcumin in 500 mg capsules form under the brand name Turcumin. In a press release here on Wednesday, the company said Curcumin is essentially an extract of turmeric and is considered to be an essential food supplement, especially in patients suffering from cancer. According to the company, Curcumin has been found to be effective in the treatment of multiple myeloma, tumours and other cancers. Intake of Curcumin, as a supplement, would be of immense benefit to patients suffering from cancer. Depending on the condition, a patient can take three to six capsules a day, the company said. Further, according to Natco, Curcumin is being widely and increasingly accepted as a potent tool in fight against cancer. Clinical studies have established the importance and distinct advantage of Curcumin in fighting cancer and other ailments, the release said.
More Stories on : Announcements | New Products & Services | Health | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|